Are you a fan of MDMA? Ever felt a bit uncomfortable when you’ve found some supply but can’t be sure you know what you’re taking? Knowing how to test MDMA is important – the market is entirely unregulated, making it very difficult to know what’s in any given dose. While Frshminds doesn’t condone recreational drug use, […]
The discovery of ketamine as a rapid-onset antidepressant and further exploration into the processes involved could significantly impact treatment for patients as well as public health worldwide. Major Depressive Disorder: A Global Concern Major Depressive Disorder (MDD) impacts over 264 million people. This makes it the leading cause of disability globally. But, issues have been […]
Most smokers can attest to always looking to kick the habit, and now research is exploring the linkage between psilocybin and smoking cessation. Johns Hopkins researchers recently completed a study of 15 people taking psilocybin, the active hallucinogenic agent in “magic mushrooms.” In the study, smokers were dosed with psilocybin, and 80% of the participants […]
Early clinical trials demonstrate that using intravenous and intranasal ketamine for unipolar and bipolar depression offers the possibility for safe and rapid relief of symptoms with high response rates (up to 88%) and pronounced antisuicidal effects. Administration of Ketamine for Unipolar and Bipolar Depression The article below is part of Frshmind’s “Psychedelic Science Snapshot Series” […]
MDMA Assisted Psychotherapy for PTSD is a relatively recent area of study. While reports in the 1970’s described the potential for MDMA to facilitate communication and connection between therapists and patients, the 80’s saw the recreational use of MDMA became popular, leading to its classification as a Schedule 1 controlled substance in 1985, and thus […]
Introduction Drugs and harm in the UK has become a central political issue. Drugs such as alcohol and tobacco products are a major cause of harm to individuals and society. They are regulated by taxation, sales, and restrictions on the age of purchase. Concern about drugs and the harm they cause in the UK has […]
By now you’ve probably heard a bit about the potential benefits of ketamine assisted psychotherapy. Read on as Frshminds’ Emily Frewster takes you behind the curtain to explore a bit of the research into ketamine assisted psychotherapy. Ketamine Assisted Psychotherapy (KAP): Patient Demographics, Clinical Data and Outcomes in Three Large Practices Administering Ketamine with Psychotherapy […]
Spoiler Alert…it involves toads! You would be mistaken if you think the history of psychedelic treatments for mental health disorders started in the 1960’s. While the first psychedelic compound was first derived in 1938 when Albert Hofmann, a Swiss researcher, synthesized LSD while working with a different chemical called ergot, ancient cultures have be using […]